Clinical Trials Browser

Phase 1/2 × mocetinostat × Tumor-Agnostic × Clear all

NCT00372437 2015-07-01

A Phase I/II Study of MGCD0103 (MG-0103) in Combination With Gemcitabine

Phase 1/2 Completed

Neoplasms